Stonepine Capital Management LLC Grows Stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Stonepine Capital Management LLC increased its holdings in Establishment Labs Holdings Inc. (NASDAQ:ESTA) by 6.7% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 80,002 shares of the company’s stock after acquiring an additional 5,002 shares during the quarter. Establishment Labs comprises 3.0% of Stonepine Capital Management LLC’s investment portfolio, making the stock its 11th biggest position. Stonepine Capital Management LLC’s holdings in Establishment Labs were worth $3,686,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Quarry LP bought a new stake in shares of Establishment Labs during the 4th quarter valued at about $27,000. R Squared Ltd purchased a new stake in Establishment Labs in the fourth quarter valued at approximately $36,000. KLP Kapitalforvaltning AS bought a new stake in Establishment Labs during the fourth quarter valued at approximately $161,000. Hood River Capital Management LLC grew its stake in Establishment Labs by 236.4% in the 4th quarter. Hood River Capital Management LLC now owns 5,920 shares of the company’s stock worth $273,000 after buying an additional 4,160 shares in the last quarter. Finally, Handelsbanken Fonder AB grew its stake in Establishment Labs by 32.3% in the 4th quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company’s stock worth $378,000 after buying an additional 2,000 shares in the last quarter. Hedge funds and other institutional investors own 72.91% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently issued reports on ESTA shares. Stephens reiterated an “overweight” rating and issued a $52.00 target price on shares of Establishment Labs in a research report on Thursday, March 6th. BTIG Research started coverage on Establishment Labs in a research note on Friday. They set a “buy” rating and a $62.00 price target for the company. Finally, Needham & Company LLC upgraded Establishment Labs from a “hold” rating to a “buy” rating and set a $48.00 price objective on the stock in a research report on Wednesday. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Establishment Labs presently has a consensus rating of “Moderate Buy” and a consensus target price of $55.33.

Establishment Labs Stock Down 1.3%

Shares of NASDAQ ESTA opened at $36.16 on Friday. The firm’s fifty day moving average is $34.41 and its 200 day moving average is $38.21. Establishment Labs Holdings Inc. has a 52 week low of $26.56 and a 52 week high of $58.00. The company has a quick ratio of 2.29, a current ratio of 3.62 and a debt-to-equity ratio of 5.94. The company has a market cap of $1.05 billion, a price-to-earnings ratio of -14.02 and a beta of 0.73.

Establishment Labs (NASDAQ:ESTA) last released its quarterly earnings data on Wednesday, May 7th. The company reported ($0.70) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.83) by $0.13. The firm had revenue of $41.38 million for the quarter, compared to analysts’ expectations of $41.15 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The company’s revenue for the quarter was up 11.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.58) earnings per share. On average, equities research analysts expect that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.